INTEG-B Integrum AB (publ)

0.8071USD8.200 SEK · STO+0.86%Mkt Cap: 21.52M USDP/E: —

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses syste…

Key Statistics

Company
Market Cap21.52M USD
Enterprise Value20.32M USD
Revenue (TTM)9.64M USD
Gross Profit6.22M USD
Net Income (TTM)-4.56M USD
Revenue/Share0.39 USD
Last Price0.8071 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees33
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0009807266
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-7.91
EV/Revenue2.11
P/S2.23
P/B1.26
EPS (TTM)-0.14 USD
EPS (Forward)—
52W Range
0.629932% of range1.175
52W High1.175 USD
52W Low0.6299 USD
Profitability
Gross Margin69.19%
Oper. Margin-37.92%
EBITDA Margin-26.64%
Profit Margin-50.71%
ROE-26.94%
ROA-22.76%
ROIC-28.48%
ROCE-29.71%
Growth
Revenue Growth27.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.04M USD
CapEx (TTM)1.67M USD
FCF Margin-30.80%
FCF Yield-13.79%
Net Debt-1.21M USD
Net Debt/EBITDA0.47
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio3.33
Quick Ratio1.96
Book Value/Sh0.64 USD
Cash/Share0.06 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.03M
Float16.15M
Insiders25.98%
Institutions18.59%
Technical
SMA 500.8608 (-6.2%)
SMA 2000.8103 (-0.4%)
Beta0.48
S&P 52W Chg12.00%
Avg Vol (30d)24.64K
Avg Vol (10d)25.52K
Technical Indicators
RSI (14)43.4
MACD-0.1390
MACD Signal-0.1647
MACD Hist.+0.0256
BB Upper0.8438 USD
BB Middle0.8127 USD
BB Lower0.7817 USD
BB Width7.63%
ATR (14)0.0307 USD
Vol Ratio (20d)1.25x

About Integrum (STO: INTEG-B)

›

Integrum (STO: INTEG-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 33 employees.

The shares were at 8.200 SEK on 19 November 2026, down 2.8% over 52 weeks. Its 52-week range is 6.400 SEK to 11.94 SEK: the price is 31.3% below the high and 28.1% above the low.

Its market capitalisation is 218.68M SEK.

Integrum reports return on equity of -26.9%, an operating margin of -37.9% and revenue up 27.2% year over year.

It holds more cash than debt, a net cash position of 12.27M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 20 November 2026.